SAGE Therapeutics Inc SAGE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EST
44.81UNCH (UNCH)
Volume
26,393
Close
44.81quote price arrow down-1.76 (-3.78%)
Volume
273,163
52 week range
27.36 - 49.56
Loading...
  • Open46.60
  • Day High46.93
  • Day Low44.75
  • Prev Close46.57
  • 52 Week High49.56
  • 52 Week High Date01/13/23
  • 52 Week Low27.36
  • 52 Week Low Date05/09/22

Key Stats

  • Market Cap2.666B
  • Shares Out59.49M
  • 10 Day Average Volume0.46M
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • YTD % Change17.49

KEY STATS

  • Open46.60
  • Day High46.93
  • Day Low44.75
  • Prev Close46.57
  • 52 Week High49.56
  • 52 Week High Date01/13/23
  • 52 Week Low27.36
  • 52 Week Low Date05/09/22
  • Market Cap2.666B
  • Shares Out59.49M
  • 10 Day Average Volume0.46M
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • YTD % Change17.49

RATIOS/PROFITABILITY

  • EPS (TTM)-8.63
  • P/E (TTM)-5.19
  • Fwd P/E (NTM)-4.71
  • EBITDA (TTM)-517.408M
  • ROE (TTM)-31.74%
  • Revenue (TTM)6.464M
  • Gross Margin (TTM)88.29%
  • Net Margin (TTM)-7,895.27%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date02/16/2023
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On SAGE Therapeutics Inc

 

Profile

MORE
Sage Therapeutics, Inc. is a biopharmaceutical company that is focused on developing and commercializing medicines with debilitating disorders of the brain. The Company's product, ZULRESSO (brexanolone) CIV injection, is for the treatment of postpartum depression (PPD) in adults. It has a portfolio of other product candidates with a focus on modulating two central nervous system (CNS) receptor systems, GABA and NMDA. It targets diseases and disorders of the brain with three...
Kevin Starr
Non-Executive Independent Chairman of the Board
Barry Greene
President, Chief Executive Officer, Director
Kimi Iguchi
Chief Financial Officer, Treasurer
Address
215 1st St
Cambridge, MA
02142-1213
United States

Top Peers

SYMBOLLASTCHG%CHG
RLAY
Relay Therapeutics Inc
20.37-0.95-4.46%
TGTX
TG Therapeutics Inc
17.90-0.53-2.88%
PCVX
Vaxcyte Inc
45.17-0.31-0.68%
PRTA
Prothena Corporation PLC
55.32-1.88-3.28%
VTYX
Ventyx Biosciences Inc
40.92-1.54-3.63%